What 6 Analyst Ratings Have To Say About Vapotherm Analysts have provided the following ratings for Vapotherm (NYSE:VAPO) within the last quarter: Benzinga · Jun 24, 2022
Looking Into Vapotherm's Return On Capital Employed Benzinga Pro data, Vapotherm (NYSE:VAPO) reported Q1 sales of $21.62 million. Earnings fell to a loss of $22.94 million, resulting in a 23.59% decrease from last quarter. Benzinga · May 20, 2022
What 4 Analyst Ratings Have To Say About Vapotherm Within the last quarter, Vapotherm (NYSE:VAPO) has observed the following analyst ratings: Benzinga · May 6, 2022
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99. Benzinga · May 6, 2022
Recap: Vapotherm Q1 Earnings Vapotherm (NYSE:VAPO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Earnings Vapotherm missed estimated earnings by 29.69%, reporting an EPS of $-0.83 versus an estimate of $-0.64. Benzinga · May 4, 2022
Canaccord Genuity Maintains Buy Rating for Vapotherm, Lowers Price Target To $12 Canaccord Genuity has decided to maintain its Buy rating of Vapotherm (NYSE:VAPO) and lower its price target from $21.00 to $12.00. Shares of Vapotherm are trading down 1.52% over the last 24 hours, at $6.48 per share. Benzinga · Apr 13, 2022